Literature DB >> 30146589

Superior Mesenteric Artery Vasculitis in Behçet's Disease: A Case Report and Literature Review.

Eiichi Kakehi1, Seiji Adachi1, Yusuke Fukuyasu1, Yasuhiro Hashimoto1, Masayo Yoshida1, Taeko Osaka1, Akane Hirotani1, Hisanori Danbara1, Kaduyo Shimizu1, Ryosuke Fujita1, Kazuhiko Kotani2, Masami Matsumura2.   

Abstract

A 55-year-old male presented with abdominal pain that had begun about 5 days ago. Physical examination revealed oral aphtha, genital aphthosis, and pseudofolliculitis, and the patient was diagnosed with incomplete Behçet's disease (BD). Contrast-enhanced computed tomography (CECT) showed dilation of the superior mesenteric artery and mesenteric infiltration of inflammation, indicating vasculo-BD. The symptoms were improved by 3-day of intravenous methylprednisolone pulse therapy followed by oral prednisolone. A literature review suggested that vasculo-BD should be included as a differential diagnosis in cases with unexplained abdominal pain, arterial dilation, and mesenteric invasion, and CECT examination and steroid therapy should be considered.

Entities:  

Keywords:  Behçet's disease; superior mesenteric artery; vascular involvement; vasculo-Behçet's disease

Mesh:

Substances:

Year:  2018        PMID: 30146589      PMCID: PMC6367084          DOI: 10.2169/internalmedicine.1290-18

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Behçet's disease (BD) is a systemic, chronic, inflammatory disease that is characterized by oral/genital aphthous ulcers and vasculitis (1). Although BD exists worldwide, its incidence is highest in the Mediterranean, Middle East, and the Far East (2). The incidence of BD in Japan is 22 per 100,000 people (3). Diagnostic criteria for BD have no specific examination findings, and complete BD only comprises about 30% of BD cases, which makes diagnosis difficult (3). The underlying cause of BD is unknown; however, infectious, autoimmune, and genetic etiologies have been considered (4). BD can affect the vascular system by causing inflammatory destruction of vessels, which can be fatal (5). The frequency of vascular involvement in BD is 7-38% (6), while arterial complications such as thrombosis, stenosis, occlusion, and aneurysm occur in only 1-7% of patients with BD (7). The arterial complications are commonly isolated, but can be multiple (8), with the abdominal aorta as the most common site (9). BD lesions of superior mesenteric artery (SMA) are very rare, but can result in arterial rupture and death (5,10). Although the general epidemiological features of vascular manifestations in patients with BD have been reported (11), the features of SMA lesions have not fully been summarized. We herein described a case of vasculo-BD with a SMA lesion, and review the relevant literature.

Case Report

A 55-year-old Japanese male was admitted to our emergency outpatient room due to fever, headache, back pain, crotch and knee joint pain, and abdominal pain that had been present for about 5 days. Although headache was recognized, meningeal irritation sign or neurological symptoms were not recognized. The abdominal pain was in the upper abdomen, and there was no nausea, vomiting, diarrhea, and/or tarry stools. The patient had previously had hyperuricemia, but had otherwise been basically healthy, expect for a vague feeling of sickness a few months ago. The patient had multiple, painful, oral aphthous ulcers (Fig. 1a). A painful ulcer was found in the right scrotum, and pseudofolliculitis was observed in the lower limbs and trunk (Fig. 1b and c).
Figure 1.

Images of a 55-year-old male with vasculo-Behçet’s disease. Multiple painful oral aphthous ulcers were observed (a). A painful ulcer was found in the right scrotum (b), and pseudofolliculitis was observed in the lower limbs and trunk (b, c).

Images of a 55-year-old male with vasculo-Behçet’s disease. Multiple painful oral aphthous ulcers were observed (a). A painful ulcer was found in the right scrotum (b), and pseudofolliculitis was observed in the lower limbs and trunk (b, c). Blood and cerebrospinal fluid test results are shown in Table 1. Blood tests on admission showed elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, while the WBC count was within normal range. A biochemical examination showed elevation of hepatobiliary enzymes. Blood culture resulted in no bacterial growth. Viral hepatitis was not detected. Further investigations showed normal immunoglobulin levels, normal C3, C4, and CH50 levels, and negative results for antinuclear antibodies. The patient tested positive for human leukocyte antigen B51, and negative for A26. Cerebrospinal pressure was slightly elevated. No increase in cell count was observed. Cerebrospinal fluid culture was negative. No increase in the concentration of IL-6 in the spinal fluid was observed. No abnormalities were recognized in a chest radiography, electrocardiography, and/or echocardiography. No abnormalities were recognized in head computed tomography (CT) and magnetic resonance imaging. Contrasted-enhancement CT (CECT) showed dilation of the SMA and its jejunal branch, and mesenteric infiltration of inflammation (Fig. 2a and b). Deep venous thrombosis was not observed in lower limb venous echo examination. A clinical diagnosis of BD was made in accordance with the International Criteria for BD, due to the history of genital aphthosis, oral aphthosis, and skin lesions (pseudofolliculitis) (1). A skin biopsy also revealed histological findings of necrotizing vasculitis. Dilatation of the SMA and its jejunal branch led to a diagnosis of vasculo-BD (10).
Table 1.

Laboratory Findings in a 55-year-old Male with Vasculo- Behçet’s Disease.

Complete blood countImmunology
WBC8,700/μLALT60IU/LIgG776mg/dL
Neu7,400/μLLDH209IU/LIgA130mg/dL
Lym570/μLALP601IU/LIgM46mg/dL
Mono680/μLγGT421IU/LC3209mg/dL
Eo10/μLCRP23.24mg/dLC444mg/dL
Ba10/μLPCT0.33ng/mLCH5084U/mL
RBC403×104/μLESR106mm/hANA<40
Hb13.8g/dLM2 Ab1.7U/mL
MCV97fLCoagulation
Hct39.2%PT12.0%Human leukocyte antigen
Plt16.9×104/μLPT-INR1.05B51+
APTT32.9sA26-
Biochemical markersD-dimer1.2μg/mL
TP6.8g/dLCerebrospinal fluid
ALB3.8g/dLInfectionLiquor pressure26cmH2O
UA3.6mg/dLHBs Ag-Appearancewatery fluid
BUN13.1mg/dLHBs Ab-Cl120meq/L
Cr0.86mg/dLHBc Ab-Protein67mg/dL
T-Bil2.5mg/dLHCV Ab-Glucose59mg/dL
D-Bil1.5mg/dLRPR-Cell count26/μL
Na135meq/LTPHA-Neu : Lym3 : 7
K4.2meq/LIFN-γ-RBC0×104/μL
Cl99meq/LBlood culture-IL-63.8pg/mL
PG81mg/dLFluid culture-
AMY54mg/dLTumor markers
CPK79IU/LFerritin526.9ng/mL
AST60IU/LsIL-2R681U/mL
Figure 2.

Contrast-enhanced computed tomography images showing dilation of the superior mesenteric artery and its jejunal branch (↓), and mesenteric infiltration of inflammation (○) (a, b). After treatment, these lesions were improved (c).

Laboratory Findings in a 55-year-old Male with Vasculo- Behçet’s Disease. Contrast-enhanced computed tomography images showing dilation of the superior mesenteric artery and its jejunal branch (↓), and mesenteric infiltration of inflammation (○) (a, b). After treatment, these lesions were improved (c). After confirmation of negative results of an interferon-ganmma release assay and hepatitis B antigen and antibodies, the patient was initially started on 1 g per day of intravenous methylprednisolone for 3 days, followed by 60 mg per day of oral prednisone. After starting treatment, the symptoms improved. The prednisone dose was able to be gradually decreased to less than 20 mg per day. There was remission of the oral aphthosis, painful ulcer in the right scrotum, and pseudofolliculitis. CRP and ESR levels were within normal ranges. The dilation of the SMA and its jejunal branch was improved (Fig. 2c). The patient was discharged in good condition after approximately 1 month.

Literature review

A search of the PubMed database was performed using the terms “Behçet's disease” AND “superior mesenteric artery” for all articles published up to January 2018; this search retrieved 15 articles. Table 2 summarized the characteristics of previous patients diagnosed with vasculo-BD involving the SMA; the average age was 35 years (range, 23-50 years), and there were 14 males (12-14,16-26) and one female (15). The complete type of BD was seen in one case (13). Three patients had ocular lesions (12,13,26), five had genital aphthosis (13-17), 11 had oral ulcers (12-18,21,24-26), and five had skin lesions (13,15,16,24,26). There were no articles reporting neurological findings in a patient with BD. A positive pathergy test was reported in three cases (16,17,25). Abdominal pain was initial chief complaint for most patients with BD (approximately 80%) (13,15-17,19,21-25).
Table 2.

Clinical Diagnosis and Treatment of Behçet’s Disease with Superior Mesenteric Artery Vasculitis.

NoReferencesAgeSexPrevious diagnosis of BDTime to diagnosis of vascular BDDiagnostic methodVascular manifestations in SMAOther affected vascular areas
11243M+9AngiographyThrombosisAneurysms of the left anterior communicating artery and celiac trunkThrombosis of subclavian arteries and inferior mesenteric arteries
21337M-0AngiographyAneurysmAneurysm of right renal artery
31423M-0US, angiographyAneurysmsAneurysm of inferior mesenteric artery
41526F-0AngiographyThrombosisNR
51641M+15Surgical explorationThrombosisNR
61732M-0US, CECTAneurysmNR
71824M+4AngiographyAneurysmAneurysms of superior branch of right renal and celiac arteryThrombosis of light anterior tibial and right popliteal artery
81939M+5US, CECTAneurysmAneurysms of left renal, left brachial, and anterior left anterior descending coronary arteriesDVT of lower extremities
92026M+2NDAneurysmAneurysms of left radial and left intracranial internal carotid arteries
102150M--4CTAneurysmAneurysms of thoracic, abdominal, and right common iliac arteries
112240M+9CECTDissectionNR
122344M+6US, CECTAneurysmNR
132435M-0CECTAneurysm and ThrombosisAneurysms of jejunum, splenic and renal arteries
142525M-0US, CECTAneurysmAneurysm of iliac artery
152630M+NDCTAneurysmAneurysms of internal carotid, coronary, celiac trunk, renal, splenic, and iliac arteries

BD: Behçet's disease, SMA: superior mesenteric artery, NR: not reported, US: ultrasonography, CT: computed tomography, CECT: contrast-enhanced CT, DVT: deep vein thrombosis, TCAE: transcatheter arterial embolization

Clinical Diagnosis and Treatment of Behçet’s Disease with Superior Mesenteric Artery Vasculitis. BD: Behçet's disease, SMA: superior mesenteric artery, NR: not reported, US: ultrasonography, CT: computed tomography, CECT: contrast-enhanced CT, DVT: deep vein thrombosis, TCAE: transcatheter arterial embolization The treatment and clinical outcome data from patients diagnosed with vasuculo-BD are summarizes in Table 3. Six patients were first diagnosed with BD at the time of the onset of vasculo-BD (13-15,17,24,25). The duration of the period from the diagnosis of BD to the onset of vasculo-BD in the SMA was 2-15 years (12,16,18-20,22,23). One case had an aneurysm in the SMA 4 years before the diagnosis of BD (21). Diagnostic methods were CT or CECT in eight patients (17,19,21-26), and angiography in five (12-15,18). Ultrasonography was used for the initial evaluation in five patients (14,17,19,23,25). Vascular pathologies included aneurysmal changes in 11 cases (13,14,17-21,23-26), thrombosis in four (12,13,16,24), and dissection in one (22). Five patients solely had a lesion in the SMA (15-17,22,23), while 10 had lesions in multiple arteries (12-14,18-21,24-26). Treatment was steroid therapy in seven cases (12,13,15,17,18,23,24), laparotomy in six (13,16,17,23-25), bypass surgery in two (20,21), and endovascular treatment in one (19). Two cases were improved with immunosuppressant therapy alone (15,18). In one case, steroid treatment alone resulted in worsening of symptoms, and so surgery was performed (13). Immunosuppressive drugs were used after laparotomy in two cases (17,24).
Table 3.

Treatment and Clinical Outcome of Data from Patients with Behçet’s Disease with Superior Mesenteric Artery Vasculitis.

NoReferencesTreatmentOutcome
112PrednisoloneNR
213PrednisoloneLaparotomySymptoms worsened with prednisolone monotherapy, and continued laparotomy was successfully performed.
314NRNR
415Prednisolone and antiplatelet agentsCorticosteroid and antiplatelet treatment was successful.
516LaparotomyLaparotomy was successfully performed. 3 year after surgical intervention, the preserved parts of the SMA were radiologically normal.
617LaparotomyPrednisolone and antiplatelet agentsLaparotomy was successfully performed, and corticosteroid and antiplatelet were prescribed. The patient was in good health at 1 year follow up.
718PrednisolonePrednisolone treatment was successfully performed.
819TCAEEndovascular treatment was successfully performed.
920Bypass surgeryThe bypass graft between the SMA and right iliac artery was successfully performed. After 2 years, the aneurysm of intracranial internal carotid artery was diagnosed and endovascular embolization was successfully performed.
1021Bypass surgeryThe aneurysm of SMA was resection and bypass surgery through left radial artery was successful. After 4 years, the size of aneurysm of thoracic and abdominal increased, and stent graft treatment was successfully performed.
1122NRNR
1223LaparotomyPrednisoloneLaparotomy was performed successfully, and corticosteroid was prescribed. The patient was in good health at six months follow up.
1324Laparotomy and anti-inflammatory medications (Prednisolone, Tripterygium wilfordii and thalidomide)The patient was in good health at eight months follow up.
1425LaparotomyLaparotomy was successfully performed.
1526NRNR

NR: not reported, TCAE: transcatheter arterial embolization, SMA: superior mesenteric artery

Treatment and Clinical Outcome of Data from Patients with Behçet’s Disease with Superior Mesenteric Artery Vasculitis. NR: not reported, TCAE: transcatheter arterial embolization, SMA: superior mesenteric artery The literature review revealed that vasuculo-BD in the SMA can occur in both the chronic phase and the acute phase of BD. Multiple vascular lesions were more common than single lesions. CECT seems to be useful for whole-body blood vessel evaluation. Early initiation of steroid therapy is indicated if the situation does not require surgical treatment.

Discussion

We reported a case of a patient with vasculo-BD who experienced abnormal pain due to a lesion in the SMA (jejunal branch), and mesenteric infiltration of inflammation. The present patient experienced unexplained pain without a previous history of BD. When there is unexplained abdominal pain in patients with BD, vasculo-BD should be considered as a differential diagnosis. Taken together with the previous literature, we consider that CECT is useful for the diagnosis of vasculo-BD, and rapid initiation of treatment with methylprednisolone pulse therapy is useful. Our literature review revealed that vasculo-BD in the SMA was more common in males than females, which is consistent with a prior report (11). Vascular involvements are thought to develop in the chronic phase after the diagnosis of BD (11). However, our literature review revealed that there were six cases with an acute onset of vasculo-BD in the SMA. The present case showed such an acute onset. This may be related to the fact that many patients with BD show an incomplete type of BD (3), and vasculo-BD can be the first manifestation of BD. In the present case, CECT revealed the SMA lesion. Diagnostic modalities used to investigate vascular involvement in patients with BD include ultrasonography, CT, CECT, and angiography. Although abdominal ultrasonography combining color and pulse Doppler can be performed initially, this method is unsuitable for evaluation of the intraperitoneal cavity, and so evaluation of the SMA is difficult. Angiography seems to be the best method for the diagnosis of aneurysms and pseudoaneurysms; however, the risk of new aneurysm formation is high in BD (27). CECT is suitable, as it can easily detect vascular abnormality and search for multiple lesions. CECT is used in many medical facilities, as it has the advantages of cost effectiveness and safety (5). Therefore, even though extensive methods like digital subtraction angiography and magnetic resonance angiography are usable, CECT is useful for the diagnosis of vasculo-BD in the SMA. The main therapeutic aim in vasculo-BD is to avoid arterial rupture (28). In the acute phase of aneurysm, high-dose prednisolone (1 mg per kg per day) or intravenous methylprednisolone pulse (1 g per day for 3 days) are recommended, and furthermore, the combined use of cyclophosphamide, methotrexate, azathioprine, cyclosporine A is positively considered (10). In addition, effective cases of infliximab, a biological agent, have also been reported (29), so considering combination therapy. Although early prednisone therapy was successful in the present case, prednisone therapy alone is more likely to result in recurrence of vasculo-BD than combined treatment with methotrexate or other immunosuppressive agents. Although HLA-B51 was positive in this case, the patient did not meet the diagnosis criteria of acute type neuro-BD (without neurological symptoms) (30). As cyclosporine A induces neuro-BD, it is not used when neuro-BD is suspected (31). The traditional treatment in vasculo-BD is also surgical treatment, but complications include occlusion of transplantation and formation of anastomotic pseudoaneurysm (32). As in the present case, early-stage steroid therapy without other immunosuppressants or biologic agents can be successful when vasculo-BD is diagnosed early. A careful follow-up is necessary to diagnosis the recurrence of vasculo-BD or onset of neuro-BD. If possible, steroid therapy should be considered for vasculo-BD in the SMA.

Conclusion

We described a patient with abdominal pain who was diagnosed with BD and vasculo-BD at the same time. Vasculo-BD should be considered in patients with BD who experience unexplained severe abdominal pain, and CECT examination and steroid therapy should be considered.

The authors state that they have no Conflict of Interest (COI).
  3 in total

1.  Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet's disease with symptoms or signs of vascular involvement: A cross-sectional study.

Authors:  Serdar Kaymaz; Halil Yilmaz; Furkan Ufuk; Ayşe Rüksan Ütebey; Veli Çobankara; Uğur Karasu; Canan Albayrak Yaşar; Firdevs Ulutaş
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

2.  Successful conservative treatment of an isolated inflammatory superior mesenteric artery aneurysm.

Authors:  Jianjun Jiang; Yang Liu; Xiangjiu Ding
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

3.  The Diagnosis and Management of Vasculo-Behçet's Disease.

Authors:  Ryusuke Yoshimi
Journal:  Intern Med       Date:  2018-08-24       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.